187 related articles for article (PubMed ID: 35330878)
1. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
2. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
Front Oncol; 2020; 10():1695. PubMed ID: 33014843
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
4. Overexpressing PLOD family genes predict poor prognosis in gastric cancer.
Li SS; Lian YF; Huang YL; Huang YH; Xiao J
J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analysis of PLOD family member expression and prognostic value in non-small cell lung cancer.
Qi Q; Huang W; Zhang H; Zhang B; Sun X; Ma J; Zhu C; Wang C
Transl Cancer Res; 2021 Jun; 10(6):2707-2724. PubMed ID: 35116582
[TBL] [Abstract][Full Text] [Related]
6. Clinical Prognostic Value of the
Meng Y; Sun J; Zhang G; Yu T; Piao H
Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
[TBL] [Abstract][Full Text] [Related]
7. PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.
Guo T; Gu C; Li B; Xu C
Lab Invest; 2021 May; 101(5):564-569. PubMed ID: 33483598
[TBL] [Abstract][Full Text] [Related]
8. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
9. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma.
Chen G; Song H; Yang Z; Du T; Zheng Y; Lu Z; Zhang K; Wei D
Front Oncol; 2022; 12():890193. PubMed ID: 35619903
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
Li X; Qiu N; Li Q
Front Genet; 2021; 12():758725. PubMed ID: 34804125
[No Abstract] [Full Text] [Related]
11. Roles of PLODs in Collagen Synthesis and Cancer Progression.
Qi Y; Xu R
Front Cell Dev Biol; 2018; 6():66. PubMed ID: 30003082
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
14. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
15. Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer.
Duan Y; Du Y; Gu Z; Zheng X; Wang C
Front Cell Dev Biol; 2022; 10():887385. PubMed ID: 35493099
[No Abstract] [Full Text] [Related]
16. Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods.
Zhao Y; Zhang X; Yao J
PLoS One; 2021; 16(1):e0246097. PubMed ID: 33503035
[TBL] [Abstract][Full Text] [Related]
17.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
Luo L; Zhang G; Wu T; Wu G
Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
[TBL] [Abstract][Full Text] [Related]
19. A Potential Prognostic Marker PRDM1 in Pancreatic Adenocarcinoma.
Zhou B; Zhang J; Zhu H; Wu S
J Oncol; 2022; 2022():1934381. PubMed ID: 35607327
[TBL] [Abstract][Full Text] [Related]
20. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]